We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Ardea Biosciences, Inc. (MM) | NASDAQ:RDEA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.96 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
LONDON--Biopharmaceutical business AstraZeneca PLC (AZN.LN) said Wednesday that on June 19 it completed its acquisition of San Diego, California-based biotechnology company Ardea Biosciences, Inc. (RDEA).
MAIN FACTS:
-Upon completion of the merger, each outstanding share of Ardea common stock was cancelled and converted into the right to receive 32 dollars, in cash, without interest, and shares of Ardea common stock ceased trading on the NASDAQ Global Select Market.
-AstraZeneca shares closed Tuesday at 2760 pence valuing the company at 34.8 billion pounds.
-Write to Ian Walker at ian.walker@dowjones.com
1 Year Ardea Biosciences, Inc. (MM) Chart |
1 Month Ardea Biosciences, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
